Published in Eur J Hum Genet on June 22, 2011
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncol (2012) 1.63
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer (2015) 1.40
Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer (2012) 1.22
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One (2012) 1.13
Increased risk of breast cancer in women with NF1. Am J Med Genet A (2012) 1.07
Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res (2012) 1.03
Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? Hum Genomics (2012) 1.02
Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol (2014) 0.91
Giant thrombosed intracavernous carotid artery aneurysm presenting as Tolosa-Hunt syndrome in a patient harboring a new pathogenic neurofibromatosis type 1 mutation: a case report and review of the literature. Neuropsychiatr Dis Treat (2014) 0.79
Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas. BMC Cancer (2015) 0.78
Comment on the article "Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri" by van den Munckhof et al. Neurogenetics (2011) 0.78
Update from the 2013 International Neurofibromatosis Conference. Am J Med Genet A (2014) 0.78
Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1 Associated with a Germline Mutation in BRCA1. J Breast Cancer (2015) 0.77
Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors. Oncogene (2016) 0.76
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions. BMC Med Genet (2012) 0.76
Association between Neurofibromatosis Type 1 and Breast Cancer: A Report of Two Cases with a Review of the Literature. Case Rep Med (2015) 0.75
The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics (2017) 0.75
Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. Br J Cancer (2016) 0.75
Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Appl Clin Genet (2013) 0.75
Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports. J Med Case Rep (2011) 0.75
Non-optic glioma in adults and children with neurofibromatosis 1. Orphanet J Rare Dis (2017) 0.75
Comprehensive pharmacological profiling of neurofibromatosis cell lines. Am J Cancer Res (2017) 0.75
Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet (2002) 5.06
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42
Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med (1986) 4.18
Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet (2001) 2.78
NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med (1990) 2.31
Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol (2005) 2.23
Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A (2010) 2.05
A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer (2006) 1.86
Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet (2007) 1.77
Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet (2005) 1.72
Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol (2006) 1.63
A clinical study of type 1 neurofibromatosis in north west England. J Med Genet (1999) 1.62
Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden. Acta Derm Venereol (1995) 1.31
Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet A (2003) 1.28
Mortality of neurofibromatosis in Japan, 1968-1992. J Dermatol (1995) 1.13
Neurofibromatosis in Gothenburg, Sweden. I. Background, study design and epidemiology. Neurofibromatosis (1989) 0.93
Sarcomas in three generations of a family with neurofibromatosis. Cancer Genet Cytogenet (1990) 0.81
Community treatment orders for patients with psychosis (OCTET): a randomised controlled trial. Lancet (2013) 11.49
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet (2006) 4.23
Advance directives for patients compulsorily admitted to hospital with serious mental illness. Randomised controlled trial. Br J Psychiatry (2002) 3.13
Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J (2004) 2.81
A novel therapeutic approach to treating obesity through modulation of TGFβ signaling. Endocrinology (2012) 1.83
LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol (2010) 1.79
Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg (2008) 1.76
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet (2012) 1.74
Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol (2005) 1.60
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet (2003) 1.52
Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2. J Med Genet (2013) 1.51
Top-10 list of herbal and supplemental medicines used by cosmetic patients: what the plastic surgeon needs to know. Plast Reconstr Surg (2006) 1.48
Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol (2012) 1.47
Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties. J Cell Sci (2007) 1.42
Mental capacity and psychiatric admission. BMJ (2008) 1.38
Neighbourhood food environment and area deprivation: spatial accessibility to grocery stores selling fresh fruit and vegetables in urban and rural settings. Int J Epidemiol (2009) 1.32
N-WASP involvement in dorsal ruffle formation in mouse embryonic fibroblasts. Mol Biol Cell (2006) 1.31
Variations in fresh fruit and vegetable quality by store type, urban-rural setting and neighbourhood deprivation in Scotland. Public Health Nutr (2009) 1.28
Autologous fat transfer national consensus survey: trends in techniques for harvest, preparation, and application, and perception of short- and long-term results. Plast Reconstr Surg (2007) 1.25
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer (2006) 1.24
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A (2011) 1.24
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A (2014) 1.20
Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet (2012) 1.20
Pseudosarcoma: massive localized lymphedema of the morbidly obese. Obes Surg (2006) 1.17
Community treatment orders: current evidence and the implications. Br J Psychiatry (2013) 1.15
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin Endocrinol (Oxf) (2003) 1.14
How mental health clinicians view community treatment orders: a national New Zealand survey. Aust N Z J Psychiatry (2004) 1.12
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer. Breast Cancer Res Treat (2013) 1.09
Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol (2008) 1.08
Nottingham knee osteoarthritis risk prediction models. Ann Rheum Dis (2011) 1.08
Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979-2003. Cancer (2008) 1.06
Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics (2013) 1.03
Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. J Neuropsychiatry Clin Neurosci (2012) 1.03
Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res (2012) 1.03
The natural history of cerebellar hemangioblastomas in von Hippel-Lindau disease. AJNR Am J Neuroradiol (2003) 1.03
Antiangiogenic therapy for von Hippel-Lindau disease. JAMA (2004) 1.03
A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health. Endocrinology (2010) 1.01
Improved ankyloglossia correction with four-flap Z-frenuloplasty. Ann Plast Surg (2005) 1.01
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset. J Med Genet (2011) 1.00
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo. Br J Pharmacol (2005) 1.00
Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med Child Neurol (2012) 1.00
CTOs: what is the state of the evidence? Soc Psychiatry Psychiatr Epidemiol (2014) 0.97
What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors? J Neurosurg (2008) 0.96
Stimulation of actin polymerization by vacuoles via Cdc42p-dependent signaling. J Biol Chem (2007) 0.95
Clostridium difficile infection among children with cancer. Pediatr Infect Dis J (2011) 0.94
High cancer mortality rates in the elderly in the UK. Cancer Epidemiol (2011) 0.93
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration. Bioorg Med Chem Lett (2009) 0.92
Cancer at ages 15-29 years: the contrasting incidence in India and England. Pediatr Blood Cancer (2010) 0.92
The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs). Hum Mutat (2006) 0.92
Community treatment orders are not a good thing. Br J Psychiatry (2008) 0.91
Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Dev Med Child Neurol (2005) 0.91
Is the veterinary profession divided and in decline? Vet Rec (2008) 0.91
Low-frequency dynamics of Caldariomyces fumago chloroperoxidase probed by femtosecond coherence spectroscopy. Biochemistry (2008) 0.91
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers. Am J Med Genet A (2010) 0.88
Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003. Eur J Cancer (2010) 0.88
Automaticity and attention in Huntington's disease: when two hands are not better than one. Neuropsychologia (2010) 0.88
Radiation-induced brachial plexopathy in women treated for carcinoma of the breast. Clin Rehabil (2002) 0.87
How patients in New Zealand view community treatment orders. J Ment Health (2005) 0.87
Weighing the Evidence of Common Beliefs in Obesity Research. Crit Rev Food Sci Nutr (2015) 0.87
Lewis antigen expression and other pathogenic factors in the presence of atrophic chronic gastritis in a European population. J Infect Dis (2002) 0.86
Delayed closure of the hard palate leads to speech problems and deleterious maxillary growth. Plast Reconstr Surg (2007) 0.85
Best practices: Best practices in the use of involuntary outpatient treatment. Psychiatr Serv (2012) 0.83
Maori experience of community treatment orders in Otago, New Zealand. Aust N Z J Psychiatry (2004) 0.83
Family perspective on community treatment orders: a New Zealand study. Int J Soc Psychiatry (2006) 0.83
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors. Bioorg Med Chem Lett (2008) 0.83
Congenital transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: study protocol. Reprod Health (2013) 0.82
Formation of and adherence to a self-disclosure norm in an online chat. Cyberpsychol Behav (2005) 0.82
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2013) 0.81
Dilemmas for clinicians in use of Community Treatment Orders. Int J Law Psychiatry (2006) 0.81
The food choice kaleidoscope. A framework for structured description of product, place and person as sources of variation in food choices. Appetite (2011) 0.81
Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation. Eur J Hum Genet (2012) 0.80
GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization. J Pharmacol Exp Ther (2011) 0.80
Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years. Eur J Cancer (2011) 0.80
Incidence of glioma in a northwestern region of England, 2006-2010. Neuro Oncol (2014) 0.79
Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis. J Med Genet (2013) 0.78
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment? BMC Med Inform Decis Mak (2014) 0.77
Capacity of forensic patients to consent to treatment. Aust N Z J Psychiatry (2012) 0.77
Spinal bone defects in neurofibromatosis type I with dural ectasia: stress fractures or dysplastic? A case series. Eur Radiol (2013) 0.77
Potential role of LPS in the outcome of Helicobacter pylori related diseases. Pol J Microbiol (2006) 0.77
Is social support universally adaptive in diabetes? A correlational study in an Arabic-speaking population with type 2 diabetes. Holist Nurs Pract (2014) 0.77
Parent questionnaires: are they effective for auditing services? Paediatr Nurs (2006) 0.77
Helicobacter pylori lipopolysaccharide in the IL-2 milieu activates lymphocytes from dyspeptic children. FEMS Immunol Med Microbiol (2003) 0.76
A quantitative characterisation of meals and their contexts in a sample of 25 to 49-year-old Spanish people. Appetite (2008) 0.76
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues. Am J Med Genet A (2014) 0.76
Myxoinflammatory fibroblastic sarcoma: a case report and review of the literature. J Foot Ankle Surg (2010) 0.76
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives. Breast Cancer Res (2013) 0.75
Commentary: toward resolving some dilemmas concerning psychiatric advance directives. J Am Acad Psychiatry Law (2006) 0.75
The OCTET RCT - a reply to Dr Mustafa. Med Sci Law (2014) 0.75
Determination of a sedative protocol for use in California sea lions (Zalophus californianus) with neurologic abnormalities undergoing electroencephalographic examination. J Zoo Wildl Med (2008) 0.75
The evolving science of care in perinatal loss. J Perinat Neonatal Nurs (2011) 0.75
Renal vascular disease in neurofibromatosis type 2: association or coincidence? Dev Med Child Neurol (2006) 0.75
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor. Bioorg Med Chem Lett (2011) 0.75
Predicting the Presence of Adjacent Infections in Septic Arthritis in Children. J Pediatr Orthop (2016) 0.75
Emerging technologies in surgical planning for breast cancer. Am J Surg (2002) 0.75
Microzooplankton grazing on phytoplankton in summer in the Jiaozhou Bay, China. Ying Yong Sheng Tai Xue Bao (2004) 0.75
Psychometric Properties of the Arabic Version of the Summary of Diabetes Self-Care Activities Instrument. Res Theory Nurs Pract (2016) 0.75